ClassID:

91947

C07C59/56 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Unsaturated compounds containing hydroxy or O-metal groups containing halogen

Recent Application in this class:
#1
20260028322
2026-01-29

PREPARATION METHOD FOR INTERMEDIATE COMPOUND ACTING AS SYNTHETIC POSACONAZOLE, AND INTERMEDIATE COMPOUND PREPARED THEREBY

#2
20240391865
2024-11-28

COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY

#3
20230271981
2023-08-31

Compounds that inhibit MCL-1 protein

#4
20230242471
2023-08-03

THYROMIMETICS

#5
20210122700
2021-04-29

Compounds for the treatment of acute brain injury

#6
20210101861
2021-04-08

NOVEL REXINOID COMPOUNDS AND METHODS OF USING REXINOID COMPOUNDS FOR TREATING METABOLIC DISORDERS AND CANCER

#7
20210094899
2021-04-01

ACRYLIC ACID ANALOGS

#8
20210040120
2021-02-11

Compounds that inhibit MCL-1 protein

#9
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#10
20200131108
2020-04-30

Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid

#11
20200062780
2020-02-27

Compounds that inhibit Mcl-1 protein

#12
20200009531
2020-01-09

Porous chiral materials and uses thereof

#13
20190390115
2019-12-26

Polymerizable polar compound, liquid crystal composition and liquid crystal display element

#14
20190284129
2019-09-19

LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE

#15
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#16
20180346408
2018-12-06

LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE

#17
20180201565
2018-07-19

Rexinoid compounds and methods of using rexinoid compounds for treating metabolic disorders and cancer

#18
20180179139
2018-06-28

GPBP inhibition using Qpeptidomimetics

#19
20180099930
2018-04-12

Method for preparing azetidinone compound and intermediate of azetidinone compound

#20
20180057440
2018-03-01

Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid

#21
20170260119
2017-09-14

Asymmetrical hydrogenation reaction of ketonic acid compound

#22
20170121281
2017-05-04

Method for preparing azetidinone compound and intermediate of azetidinone compound

#23
20170057941
2017-03-02

Substituted arylcyclopentenes as therapeutic agents

#24
20140323510
2014-10-30

Substituted arylcyclopentenes as therapeutic agents

#25
20140171388
2014-06-19

Compound for treating cartilage disorders

#26
20140080852
2014-03-20

GPBP inhibition using Q2 peptidomimetics

#27
20140058125
2014-02-27

Ortho-fluoro substituted compounds for the treatment of metabolic diseases

#28
20130197260
2013-08-01

Processes for the preparation of fesoterodine

#29
20120016158
2012-01-19

Loxoprofen derivative and pharmaceutical preparation containing the same

#30
20110263692
2011-10-27

Therapeutic compounds

#31
20110144207
2011-06-16

ARYL ALKYL CARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION AND DOSAGE FORMS

#32
20110105545
2011-05-05

GPBP inhibition using Qpeptidomimetics

#33
20110092554
2011-04-21

1,3,5 TRI-SUBTITUTED BENZENES FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS

#34
20110086911
2011-04-14

NOVEL BISMUTH(III) NSAID COMPOUNDS AND METHODS FOR THEIR USE

#35
20110060146
2011-03-10

VITAMIN-D-LIKE COMPOUNDS

#36
20100317872
2010-12-16

Therapeutic compounds

#37
20100288004
2010-11-18

Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use

#38
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#39
20100217027
2010-08-26

PROCESS FOR PRODUCTION PHENOL DERIVATIVES SUBSTITUTED WITH IODINE AT ORTHO POSITION

#40
20100204199
2010-08-12

Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors

#41
20100087651
2010-04-08

NEW MANDELIC ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS

#42
20090253659
2009-10-08

Cycloalkylidene compounds as modulators of estrogen receptor

#43
20090238784
2009-09-24

Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof

#44
20090203654
2009-08-13

Cosmetic and pharmaceutical compositions comprising compounds that display retinoid like activities

#45
20090137609
2009-05-28

Vitamin D-like compound

#46
20090105288
2009-04-23

Carbon linked modulators of gamma-secretase

#47
20090016981
2009-01-15

THERAPEUTIC COMPOUNDS

#48
20080312321
2008-12-18

Therapeutic substituted cyclopentanes

#49
20080281114
2008-11-13

Method for preparing unsaturated fatty hydroxyacids

#50
20080255078
2008-10-16

Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators

#51
20080234356
2008-09-25

2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives

#52
20080234249
2008-09-25

Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors

#53
20080234199
2008-09-25

Chemical Compounds

#54
20080090800
2008-04-17

Mandelic acid derivatives and their use as thrombin inhibitors

#55
20080064660
2008-03-13

Modulation of Inflammation Related to Columnar Epithelia

#56
20070259947
2007-11-08

Therapeutic compounds

#57
20070259836
2007-11-08

Therapeutic cyclopentane derivatives

#58
20070254957
2007-11-01

Triaryl compounds and derivates thereof

#59
20070225520
2007-09-27

Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid

#60
20070218136
2007-09-20

New mandelic acid derivatives and their use as thrombin inhibitors

#61
20070213569
2007-09-13

Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene

#62
20070213348
2007-09-13

Cycloalkylidene compounds as modulators of estrogen receptor

#63
20070202174
2007-08-30

Mandelic acid derivatives and their use as thrombin inhibitors

#64
20070155839
2007-07-05

Cycloalkylidene compounds as modulators of estrogen receptor

#65
20070155813
2007-07-05

Hsp90 family protein inhibitors

#66
20070027204
2007-02-01

2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives

#67
20060293536
2006-12-28

Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids

#68
20060264513
2006-11-23

Phenoxy carboxylic acid compounds and compositions for delivering active agents

#69
20060205800
2006-09-14

Therapeutic compounds

#70
20060160875
2006-07-20

Matrix metalloproteinase inhibitors

#71
20060148894
2006-07-06

12-Aryl prostaglandin analogs

#72
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#73
20050192449
2005-09-01

Compounds with hydroxycarbonyl-halogenoalkyl side chains

#74
20050113366
2005-05-26

Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses

#75
20050054727
2005-03-10

Phenyl naphthol ligands for thyroid hormone receptor

#76
20050038122
2005-02-17

Phenyl naphthol ligands for thyroid hormone receptor

#77
20050020849
2005-01-27

Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids

#78
20050009909
2005-01-13

Carboxylic compound and medicine comprising the same